IMKELDI

Formula & Concentration

IMKELDI – imatinib 80 mg/mL oral solution

Manufacturer

Shorla Oncology Inc.

Indications

Chronic phase Philadelphia chromosome (+) CML; malignancy; accelerated phase Philadelphia chromosome (+) CML; lymphoid blast phase Philadelphia chromosome (+) CML; aggressive systemic mastocytosis; Philadelphia chromosome positive ALL; myeloid blast phase Philadelphia chromosome (+) CML; hypereosinophilic syndrome; dermatofibrosarcoma protuberans; chronic eosinophilic leukemia; unresect or metastatic CD117+ gastrointest stromal tumor; myelodysplastic, myeloproliferative diseases with PDGFR; adjuvant therapy of CD117+ gastrointest stromal tumor

Product Options

Package Size

NDC #

Presentation

80 mg/mL

81927-0201-01

Solution

Shelf Life and Storage

Controlled Room Temp (20-25°C)